Document is current

Article History

Received: 19 December 2023

Revised: 19 December 2023

Accepted: 22 December 2023

First Online: 15 March 2024

Declarations

:

: The scientific guarantor of this publication is Valérie VILGRAIN.

: Mohamed Bouattour reports consulting fees from AstraZeneca, Bayer, Bristol Myers Squibb, Eisai, Ipsen, MSD, Roche, and Sirtex Medical; speakers bureau from Bayer, Eisai, and Roche; and support for travel/attending meetings from AstraZeneca, Bayer, and Sirtex Medical.Valérie Vilgrain and Ailton Sepulveda have no conflicts of interest to disclose.

: No complex statistical methods were necessary for this paper.

: Written informed consent was not required.

: Institutional Review Board approval was not required.

: Not applicable.

: • commentary